PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

Circulating FH Protects Kidneys From Tubular Injury During Systemic Hemolysis.

Mouse / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 32849636 ↗2020Reported benefit

Circulating FH Protects Kidneys From Tubular Injury During Systemic Hemolysis.

MouseChemical/toxinC57BL/6 wild type and hepatocyte-specific Cfh knockout C57BL/6 (hepatoFH-/-, approximately 20% residual Factor H)n = 4 mice per experimental group, from one experimentintravenous per Methods; the Results text instead describes a single intraperitoneal injection250 microlitre of 1 mg/mL (0.25 mg) per injection, equivale…pre-treatment, 3 h and 1 h before phenylhydrazine

Model: Phenylhydrazine-induced acute systemic intravascular haemolysis, 900 micromol/kg (0.125 mg/g body weight) in 100 microlitre intraperitoneally as a single injection, with sacrifice at 6 h, day 1, day 2 or day 4; comparator injury models were LPS 2 mg/kg and cisplatin 15 mg/kg intraperitoneally

In hepatoFH-/- mice, phenylhydrazine raised blood urea at day 2 and this was prevented by pre-injection of purified human Factor H, which also partially prevented the rise in renal NGAL and Kim-1 and prevented systemic C3 cleavage. No effect was seen in wild type mice, in which tubular injury marke…

Extraction: extract · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.